Terray Therapeutics Sales Trigger: Board Expansion Ignites AI Pipeline

🚀 Battle Card

🚀 Battle Card: Terray Therapeutics

• Wendy Young, Ph.D., Board of Directors Member · 🔗 [LinkedIn](https://www.linkedin.com/company/terray-therapeutics/)

• This Terray Therapeutics sales trigger signals a major push to scale AI-driven small molecule pipelines with veteran drug discovery leadership. → Source

• Ramping AI-native workflows to handle billion-scale ligand-protein datasets

• Building executive infrastructure to accelerate IND-ready candidates

• Primary: DataOps Automation Suite → maximize throughput on proprietary AI datasets

• Expansion: Biotech Board Advisory Services → infuse seasoned governance and strategic oversight

• HQ: Los Angeles, CA

• Employees: ≈ 150

• Rev: ≈ $80 M

• Website: [terraytx.com](https://terraytx.com/)

🤼 Competitive Intel

• Schrödinger — AI-driven R&D platform
• Unique edge: Physics-based simulation accuracy
• Evaluated by VP R&D for predictive modeling

• Insilico Medicine — AI drug discovery
• Unique edge: Generative chemistry pipelines
• Evaluated by Head of Discovery for novel scaffold ID

• Atomwise — Deep learning screening
• Unique edge: Billion-compound virtual screens
• Evaluated by Dir. Computational Chem for hit-finding speed

• Exscientia — Automated molecule design
• Unique edge: Closed-loop AI experimentation
• Evaluated by Chief Scientific Officer for design-to-clinic timelines

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑ ❑
OFFER_BRIEF   = ❑ ❑
PROOF_METRIC  = ❑ ❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Wendy
COMPANY     = Terray Therapeutics
DEPT        = Board of Directors
SIZE        = 7
BOTTLENECK  = ramping AI-native workflows to handle billion-scale ligand-protein datasets
EVENT       = Board expansion
DETAIL      = appointment of Wendy Young, Ph.D.
PAIN        = need to scale AI-driven small molecule pipelines
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250923211610&div=41152219
SIM_CO      = Schrödinger
WIN_METRIC  = 30% faster candidate ID
NEXT_SIZE   = 15
EMP_EST     = ≈ 150
REV_EST     = ≈ $80M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: 7-person Board of Directors

Wendy—noticed your Board of Directors team is ≈ 7.

That’s when ramping AI-native workflows to handle billion-scale ligand-protein datasets slows growth.

We helped Schrödinger fix this with ❑ ❑.

Result: 30% faster candidate ID.  
Quick call?

PS—next bottleneck hits ≈ 15.

DM ≤45 words, TONE:
Saw your post about appointment of Wendy Young, Ph.D. — need to scale AI-driven small molecule pipelines.  
❑ ❑. ❑ ❑.  
Quick chat?